Jeremiah R Brown1, Robert S Kramer, Steven G Coca, Chirag R Parikh. 1. The Dartmouth Institute for Health Policy and Clinical Practice, Section of Cardiology, Dartmouth-Hitchcock Medical Center and Dartmouth Medical School, Lebanon, New Hampshire, USA. jbrown@dartmouth.edu
Abstract
BACKGROUND: Acute kidney injury (AKI) after cardiac surgery is associated with worse outcomes. However, it is not known how adverse long-term consequences vary according to the duration of AKI. We sought to determine the association between duration of AKI and survival. METHODS: Medical records of 4,987 cardiac surgery patients from 2002 through 2007 with serum creatinine (SCr) collection at a medical center in northern New England were reviewed. Acute kidney injury was defined as at least a 0.3 (mg/dL) or at least a 50% increase in SCr from baseline and further classified into AKI Network stages. Duration of AKI was defined by the number of days AKI was present and categorized as no AKI and AKI for 1 to 2, 3 to 6, and at least 7 days. RESULTS: Thirty-nine percent of patients exhibited AKI. Long-term survival was significantly different by AKI duration (p < 0.001). The proportion of patients with AKI duration, adjusted hazard ratio, and 95% confidence interval for mortality (no AKI as referent) were as follows: 1 to 2 days (18%; adjusted hazard ratio, 1.66; 95% confidence interval, 1.32 to 2.09), 3 to 6 days (11%; adjusted hazard ratio, 1.94; 95% confidence interval, 1.51 to 2.49), ≥7 days (9%; adjusted hazard ratio, 3.40; 95% confidence interval, 2.73 to 4.25). This graded relationship of duration of AKI with long-term mortality persisted when patients who died during hospitalization were excluded from analysis (p < 0.001). Propensity-matched analysis confirmed results. CONCLUSIONS: The duration of AKI after cardiac surgery is directly proportional to long-term mortality. This AKI dose-dependent effect on long-term mortality helps to close the gap between association and causation, whereby AKI stages and AKI duration have important implications for patient care and can aid clinicians in evaluating the risk of in-hospital and postdischarge death.
BACKGROUND:Acute kidney injury (AKI) after cardiac surgery is associated with worse outcomes. However, it is not known how adverse long-term consequences vary according to the duration of AKI. We sought to determine the association between duration of AKI and survival. METHODS: Medical records of 4,987 cardiac surgery patients from 2002 through 2007 with serum creatinine (SCr) collection at a medical center in northern New England were reviewed. Acute kidney injury was defined as at least a 0.3 (mg/dL) or at least a 50% increase in SCr from baseline and further classified into AKI Network stages. Duration of AKI was defined by the number of days AKI was present and categorized as no AKI and AKI for 1 to 2, 3 to 6, and at least 7 days. RESULTS: Thirty-nine percent of patients exhibited AKI. Long-term survival was significantly different by AKI duration (p < 0.001). The proportion of patients with AKI duration, adjusted hazard ratio, and 95% confidence interval for mortality (no AKI as referent) were as follows: 1 to 2 days (18%; adjusted hazard ratio, 1.66; 95% confidence interval, 1.32 to 2.09), 3 to 6 days (11%; adjusted hazard ratio, 1.94; 95% confidence interval, 1.51 to 2.49), ≥7 days (9%; adjusted hazard ratio, 3.40; 95% confidence interval, 2.73 to 4.25). This graded relationship of duration of AKI with long-term mortality persisted when patients who died during hospitalization were excluded from analysis (p < 0.001). Propensity-matched analysis confirmed results. CONCLUSIONS: The duration of AKI after cardiac surgery is directly proportional to long-term mortality. This AKI dose-dependent effect on long-term mortality helps to close the gap between association and causation, whereby AKI stages and AKI duration have important implications for patient care and can aid clinicians in evaluating the risk of in-hospital and postdischarge death.
Authors: Azra Bihorac; Sinan Yavas; Sophie Subbiah; Charles E Hobson; Jesse D Schold; Andrea Gabrielli; A Joseph Layon; Mark S Segal Journal: Ann Surg Date: 2009-05 Impact factor: 12.969
Authors: Jeremiah R Brown; Richard P Cochran; Todd A MacKenzie; Anthony P Furnary; Karyn S Kunzelman; Cathy S Ross; Craig W Langner; David C Charlesworth; Bruce J Leavitt; Lawrence J Dacey; Robert E Helm; John H Braxton; Robert A Clough; Robert F Dunton; Gerald T O'Connor Journal: Ann Thorac Surg Date: 2008-07 Impact factor: 4.330
Authors: Charles E Hobson; Sinan Yavas; Mark S Segal; Jesse D Schold; Curtis G Tribble; A Joseph Layon; Azra Bihorac Journal: Circulation Date: 2009-04-27 Impact factor: 29.690
Authors: Roland Schmitt; Steven Coca; Mehmet Kanbay; Mary E Tinetti; Lloyd G Cantley; Chirag R Parikh Journal: Am J Kidney Dis Date: 2008-05-29 Impact factor: 8.860
Authors: Michael Joannidis; Barbara Metnitz; Peter Bauer; Nicola Schusterschitz; Rui Moreno; Wilfred Druml; Philipp G H Metnitz Journal: Intensive Care Med Date: 2009-06-23 Impact factor: 17.440
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: José António Lopes; Paulo Fernandes; Sofia Jorge; Sara Gonçalves; António Alvarez; Zélia Costa e Silva; Carlos França; Mateus Martins Prata Journal: Crit Care Date: 2008-08-28 Impact factor: 9.097
Authors: Jeremiah R Brown; Michael E Rezaee; William M Hisey; Kevin C Cox; Michael E Matheny; Mark J Sarnak Journal: Am J Nephrol Date: 2016-04-29 Impact factor: 3.754
Authors: Jeremiah R Brown; Heather Thiessen-Philbrook; Christine A Goodrich; Andrew R Bohm; Shama S Alam; Steven G Coca; Eric McArthur; Amit X Garg; Chirag R Parikh Journal: Ann Thorac Surg Date: 2019-03-14 Impact factor: 4.330
Authors: Kevin W Lobdell; Devin M Parker; Donald S Likosky; Michael Rezaee; Moritz Wyler von Ballmoos; Shama S Alam; Sherry Owens; Heather Thiessen-Philbrook; Todd MacKenzie; Jeremiah R Brown Journal: J Thorac Cardiovasc Surg Date: 2018-04-11 Impact factor: 5.209
Authors: Bixiao Zhao; Qiongshi Lu; Yuwei Cheng; Justin M Belcher; Edward D Siew; David E Leaf; Simon C Body; Amanda A Fox; Sushrut S Waikar; Charles D Collard; Heather Thiessen-Philbrook; T Alp Ikizler; Lorraine B Ware; Charles L Edelstein; Amit X Garg; Murim Choi; Jennifer A Schaub; Hongyu Zhao; Richard P Lifton; Chirag R Parikh Journal: Am J Respir Crit Care Med Date: 2017-02-15 Impact factor: 21.405
Authors: David S Cooper; Donna Claes; Stuart L Goldstein; Michael R Bennett; Qing Ma; Prasad Devarajan; Catherine D Krawczeski Journal: Clin J Am Soc Nephrol Date: 2015-11-17 Impact factor: 8.237